(Cornea[TA])
9,244 results
  • Pediatric Corneal Neurotization for Neurotrophic Keratopathy: A Systematic Review. [Journal Article]
    Cornea. 2026 Sep 21. [Online ahead of print]Gaeta A, Ottonelli G, … Di Maria AC
  • CONCLUSIONS: CN may represent a promising option for selected pediatric patients with NK, with most reports describing improved corneal sensitivity and ocular surface stability. However, evidence remains limited by single case reports and small case series, heterogeneous outcome reporting, and low or very low certainty. Postoperative visual outcomes are variable.
  • Ocular Adverse Events Associated With Dupilumab: Analysis From a Real-World Database. [Journal Article]
    Cornea. 2026 Sep 21. [Online ahead of print]Elaraby O, Wai KM, … Rahimy EC
  • CONCLUSIONS: Our study found a low frequency of documented ocular adverse events among patients treated with dupilumab. Although routine ophthalmic screening for all patients initiating dupilumab may not be necessary, prescribing physicians should remain vigilant for ocular surface inflammation, particularly in patients with atopic dermatitis, and promptly refer patients who develop ocular symptoms for ophthalmic evaluation.
  • Ocular Surface Disease as an Immune-related Adverse Event of Immune Checkpoint Inhibitor Therapy. [Journal Article]
    Cornea. 2026 Sep 09. [Online ahead of print]Frey C, Etminan M, Yeung SNC
  • CONCLUSIONS: Immune-mediated scleritis generated the strongest disproportionality signal in this analysis among PD-1 inhibitors, although these estimates are based on small case counts and wide confidence intervals and should be regarded as hypothesis-generating. Sicca syndrome and keratitis were reported across multiple ICI classes, with the keratitis signals for nivolumab and pembrolizumab supported by the largest case counts. As a disproportionality analysis, this study cannot establish incidence, comparative risk, or causality; the findings support clinical vigilance and further epidemiologic study rather than definitive causal conclusions. Physicians managing ICI-treated patients should have a low threshold for ophthalmological referral when ocular symptoms arise.
  • Acanthamoeba and Microsporidia Coinfection Causing Refractory Stromal Keratitis in an Immunosuppressed Patient: A Case Report. [Journal Article]
    Cornea. 2026 Aug 31. [Online ahead of print]Pariyakanok L, Choksuwatnasakul S, … Satitpitakul VC
  • CONCLUSIONS: Coinfection with Acanthamoeba and microsporidia should be considered in immunocompromised patients presenting with atypical, treatment-resistant keratitis. Prompt and parallel diagnostic evaluation-including corneal scraping, IVCM, culture, and PCR-based pathogen identification-is essential. When medical therapy fails, therapeutic keratoplasty may be required. Early comprehensive diagnosis may prevent disease progression and need for surgical intervention.
  • Management of Corneal Endothelial Failure in Eyes With a PreserFlo MicroShunt. [Journal Article]
    Cornea. 2026 Sep 02. [Online ahead of print]Weller JM, Eberle JV, … Lämmer RC
  • CONCLUSIONS: Endothelial failure in eyes with PFM was observed mainly in eyes with further risk factors for endothelial impairment as Fuchs endothelial corneal dystrophy, pseudoexfoliation glaucoma, or multiple previous surgeries. DMEK with simultaneous or sequential intracameral tube shortening is a feasible option in this setting.